T
GILD icon

Tidemark’s Gilead Sciences GILD Stock Holding History

Tidemark’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Sell
2,845
-178
-6% -$23.5K 0.08% 104
2026
Q1 		$421K Buy
3,023
+869
+40% +$122K 0.11% 89
2025
Q4 		$264K Sell
2,154
-29
-1% -$3.52K 0.08% 109
2025
Q3 		$242K Hold
2,183
– – 0.07% 116
2025
Q2 		$242K Buy
2,183
+14
+0.6% +$1.49K 0.08% 107
2025
Q1 		$243K Hold
2,169
– – 0.09% 104
2024
Q4 		$200K Hold
2,169
– – 0.08% 111
2024
Q3 		$182K Sell
2,169
-26
-1% -$1.98K 0.07% 114
2024
Q2 		$151K Hold
2,195
– – 0.07% 126
2024
Q1 		$161K Hold
2,195
– – 0.09% 138
2023
Q4 		$178K Buy
+2,195
New +$171K 0.11% 119

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tidemark's GILD Position: Q2 2026 in Review

Tidemark reduced its Gilead Sciences (GILD) stake by 5.9% in Q2 2026, selling an estimated $23.5K and leaving 2,845 shares worth $359K. The position accounts for 0.08% of the portfolio, ranked #104.

Tidemark first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $421K in Q1 2026. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Tidemark held 2,845 shares of Gilead Sciences worth $359K as of Q2 2026.
  • Tidemark sold 178 Gilead Sciences shares in Q2 2026, an estimated $23.5K.
  • Gilead Sciences made up 0.08% of Tidemark's portfolio in Q2 2026, its #104 holding.
  • Tidemark first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Tidemark's Gilead Sciences position peaked at $421K in Q1 2026.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.